oncology news
....A total of 39 patients (4.0%) had a VUS in a BRCA1 or BRCA2
gene, with little difference between those who underwent multi-gene
screening or limited testing. However, among women who underwent
multi-gene panel testing, an additional 3.9 percent harbored non-BRCA pathogenic mutations and 10.1 percent had a non-BRCA VUS.....
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.